Recombinate recombinant and Ustekinumab Intravenous Infusion
Determining the interaction of Recombinate recombinant and Ustekinumab Intravenous Infusion and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant), Recombinate
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Recombinate recombinant-Ustekinumab Subcutaneous
- Recombinate recombinant-Ustekinumab Subcutaneous Injection
- Recombinate recombinant-Ustell
- Recombinate recombinant-UTA
- Recombinate recombinant-UTA Capsules
- Recombinate recombinant-UTAC tablets
- Ustekinumab Intravenous Infusion-Recombivax
- Ustekinumab Intravenous Infusion-Recombivax HB
- Ustekinumab Intravenous Infusion-Recombivax HB Adult
- Ustekinumab Intravenous Infusion-Recombivax HB Dialysis Formulation
- Ustekinumab Intravenous Infusion-Recombivax HB Pediatric/Adolescent
- Ustekinumab Intravenous Infusion-Recort Plus